{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:23:43Z","timestamp":1768688623757,"version":"3.49.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1749,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.jhep.2008.06.003","type":"journal-article","created":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T08:42:00Z","timestamp":1214556120000},"page":"613-624","source":"Crossref","is-referenced-by-count":92,"title":["Hepatitis C virus and kidney disease"],"prefix":"10.1016","volume":"49","author":[{"given":"Paul","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Fabrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2008.06.003_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1525-139X.2005.18108.x","article-title":"National surveillance of dialysis-associated diseases in the United States, 2002","volume":"18","author":"Finelli","year":"2005","journal-title":"Semin Dial"},{"key":"10.1016\/j.jhep.2008.06.003_bib2","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOOPS","volume":"65","author":"Fissell","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/ndt\/gfh012","article-title":"The changing epidemiology of hepatitis C virus infection in hemodialysis: European multicentre study","volume":"19","author":"Jadoul","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jhep.2002.34613","article-title":"Hepatitis C infection and the patient with end-stage renal disease","volume":"36","author":"Fabrizi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.06.003_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/infdis\/168.6.1343","article-title":"High prevalence of hepatitis C virus (HCV) DNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection","volume":"168","author":"Bukh","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib6","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1128\/JCM.36.6.1711-1715.1998","article-title":"Hepatitis C virus infection in dialysis centers in The Netherlands: a national survey by serological and molecular methods","volume":"36","author":"Schneeberger","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2008.06.003_bib7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(96)91397-5","article-title":"Destruction of hepatitis C virus particles by hemodialysis","volume":"347","author":"Okuda","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2008.06.003_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jcv.2005.05.007","article-title":"HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection on hemodialysis: results from five hemodialysis units in central Greece","volume":"34","author":"Rigopoulos","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhep.2008.06.003_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1053\/j.ajkd.2005.05.006","article-title":"Diagnostic discordance for hepatitis C virus infection in hemodialysis patients","volume":"46","author":"Kalantar-Zadeh","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib10","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jmv.21003","article-title":"Detection and quantification of HCV RNA using real-time PCR after automated sample processing","volume":"79","author":"Sanders-Saune","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2008.06.003_bib11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/jmv.21190","article-title":"Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis","volume":"80","author":"Kaiser","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2008.06.003_bib12","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/ndt\/14.1.40","article-title":"Hepatitis virus infection in haemodialysis patients from Moldavia","volume":"14","author":"Covic","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000076951","article-title":"The impact of nurse understaffing on the transmission of hepatitis C virus in a hospital-based hemodialysis unit","volume":"13","author":"Saxena","year":"2004","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.jhep.2008.06.003_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20526","article-title":"Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission","volume":"78","author":"Hmajed","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2008.06.003_bib15","first-page":"44","article-title":"Antibody to hepatitis C virus increases with time on hemodialysis","volume":"38","author":"Hardy","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jhep.2008.06.003_bib16","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/JCM.34.7.1633-1636.1996","article-title":"High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence","volume":"34","author":"Pujol","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2008.06.003_bib17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/ndt\/6.12.944","article-title":"Hepatitis C infection among dialysis patients: a comparison between patients on maintenance hemodialysis and continuous ambulatory peritoneal dialysis","volume":"6","author":"Chan","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/039139889001301105","article-title":"Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients","volume":"13","author":"Gilli","year":"1990","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jhep.2008.06.003_bib19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/oxfordjournals.ndt.a027359","article-title":"Hepatitis C virus genotypes in chronic dialysis patients","volume":"11","author":"Fabrizi","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0168-8278(95)80307-6","article-title":"Mode of hepatitis C infection not associated with blood transfusions among chronic haemodialysis patients","volume":"23","author":"Okuda","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.06.003_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1365-2893.2002.00374.x","article-title":"A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C virus in a haemodialysis unit","volume":"9","author":"Kokubo","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2008.06.003_bib22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0272-6386(05)80017-4","article-title":"Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis","volume":"37","author":"Petrosillo","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jmv.1890430417","article-title":"Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment","volume":"43","author":"Allander","year":"1994","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2008.06.003_bib24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1086\/502613","article-title":"A large nosocomial outbreak of hepatitis C virus infection at a hemodialysis center","volume":"26","author":"Savey","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhep.2008.06.003_bib25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/ndt\/14.5.1337b","article-title":"Isolation of HCV patients is efficient in reducing the annual incidence of HCV infection, but is it necessary?","volume":"14","author":"Arenas","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib26","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/ndt\/gfh759","article-title":"A multicentre survey of the practice of hand hygiene in haemodialysis units: factors affecting compliance","volume":"20","author":"Arenas","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ki.1994.301","article-title":"A twelve year natural history of hepatitis C virus infection in hemodialyzed patients","volume":"46","author":"Simon","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib28","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/oxfordjournals.ndt.a027090","article-title":"Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units","volume":"11","author":"dos Santos","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib29","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1523-1755.1998.00823.x","article-title":"Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian multicenter study","volume":"53","author":"Jadoul","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000188608","article-title":"Prevention of hepatitis C virus in dialysis units","volume":"70","author":"Gilli","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.jhep.2008.06.003_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.510290132","article-title":"Preventing hepatitis B and hepatitis C virus infections in end-stage renal disease patients: back to basics","volume":"29","author":"Kellerman","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.06.003_bib32","unstructured":"Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 2001; 50: 1\u201343."},{"key":"10.1016\/j.jhep.2008.06.003_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000045215","article-title":"Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey","volume":"80","author":"Fabrizi","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.jhep.2008.06.003_bib34","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1681\/ASN.V11101896","article-title":"Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy","volume":"11","author":"Nakayama","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2008.06.003_bib35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(98)70027-7","article-title":"Risk of death among chronic dialysis patients infected with HCV","volume":"32","author":"Stehman-Breen","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.ajkd.2006.07.004","article-title":"Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region","volume":"48","author":"Di Napoli","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib37","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/ndt\/gfh895","article-title":"Clinical characteristics and mortality in hepatitis C-positive hemodialysis patients: a population-based study","volume":"20","author":"Kalantar-Zadeh","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2893.2007.00868.x","article-title":"The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies","volume":"14","author":"Fabrizi","year":"2007","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.jhep.2008.06.003_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.510290123","article-title":"Impact of hepatitis B and C virus on kidney transplantation outcome","volume":"29","author":"Mathurin","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.06.003_bib40","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1600-6143.2005.00864.x","article-title":"Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib41","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00007890-199610270-00004","article-title":"The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients","volume":"62","author":"Cosio","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2008.06.003_bib42","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/00007890-199506270-00006","article-title":"De novo membranoproliferative glomerulonephritis in hepatitis C virus infected renal allograft recipients","volume":"59","author":"Roth","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2008.06.003_bib43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.transproceed.2005.12.109","article-title":"De novo glomerulonephritis in renal allografts with hepatitis C virus infection","volume":"38","author":"Ozdemir","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2008.06.003_bib44","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/00007890-199706150-00017","article-title":"Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients","volume":"63","author":"Morales","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2008.06.003_bib45","doi-asserted-by":"crossref","first-page":"c133","DOI":"10.1159\/000085442","article-title":"Interferon therapy in hemodialysis patients with chronic hepatitis C: study of tolerance, efficacy and post-transplantation course","volume":"100","author":"Mahmoud","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jhep.2008.06.003_bib46","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1097\/01.ASN.0000145439.48387.BF","article-title":"Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus","volume":"15","author":"Abbott","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2008.06.003_bib47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1572-0241.1999.00788.x","article-title":"Comparison of clinical features and liver histology in hepatitis C positive patients and renal transplant recipients","volume":"94","author":"Glicklich","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.06.003_bib48","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/00007890-200004150-00045","article-title":"Histopathological features of hepatitis C in renal transplant candidates","volume":"69","author":"Martin","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2008.06.003_bib49","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1111\/j.1572-0241.1999.01649.x","article-title":"Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting liver transplantation","volume":"94","author":"Sterling","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.06.003_bib50","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/hep.21420","article-title":"Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases","volume":"44","author":"Ganne-Carrie","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.06.003_bib51","unstructured":"Kidney disease improving global outcomes (KDIGO): clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008;109:S1\u2013S99."},{"key":"10.1016\/j.jhep.2008.06.003_bib52","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJM199108153250702","article-title":"Transmission of hepatitis C virus by organ transplantation","volume":"325","author":"Pereira","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.06.003_bib53","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/BF00867680","article-title":"Transmission of hepatitis C virus by kidney transplantation: impact of perfusion techniques and course of viremia post transplant","volume":"9","author":"Roth","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jhep.2008.06.003_bib54","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/00007890-199403270-00011","article-title":"Depletion of hepatitis C virus from procured kidneys using pulsatile perfusion preservation","volume":"57","author":"Zucker","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2008.06.003_bib55","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ki.1997.403","article-title":"Hepatitis C in renal transplantation","volume":"52","author":"Vosnides","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib56","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ki.1995.29","article-title":"Transplantation of kidneys from donors with hepatitis C antibody to recipients with pre-transplantation anti-HCV","volume":"47","author":"Morales","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib57","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/00007890-199812270-00021","article-title":"Donor hepatitis virus status does not adversely short-term outcomes in HCV positive recipients in renal transplantation","volume":"66","author":"Ali","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2008.06.003_bib58","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1097\/01.ASN.0000034944.90425.75","article-title":"Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation","volume":"13","author":"Bucci","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2008.06.003_bib59","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1600-6143.2004.00606.x","article-title":"The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients","volume":"4","author":"Abbott","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib60","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00007890-199510150-00004","article-title":"Hepatitis C superinfection in hepatitis C virus -infected patients transplanted with an HCV-infected kidney","volume":"60","author":"Widell","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2008.06.003_bib61","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1600-6143.2004.00504.x","article-title":"Severe hepatitis C infection in a renal transplant recipient following hepatitis C genotype mismatch transplant","volume":"4","author":"Schussler","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib62","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1046\/j.1523-1755.1999.00594.x","article-title":"Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group","volume":"56","author":"Natov","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib63","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ki.1995.198","article-title":"Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients","volume":"47","author":"Pol","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib64","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/ki.1994.197","article-title":"Interferon treatment for chronic hepatitis C virus infection in uremic patients","volume":"45","author":"Koenig","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib65","first-page":"1170","article-title":"Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation","volume":"96","author":"Casanovas-Taltavull","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.06.003_bib66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2893.1997.tb00213.x","article-title":"Nephrologists group for the study of HCV infection and Viola L. A double-blind controlled trial of recombinant interferon-alpha2b in hemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels","volume":"4","author":"Fernandez","year":"1997","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2008.06.003_bib67","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1081\/JDI-200031725","article-title":"A six-year follow-up after interferon-alpha monotherapy for chronic hepatitis C infection in hemodialysis patients","volume":"26","author":"Ozdemir","year":"2004","journal-title":"Ren Fail"},{"key":"10.1016\/j.jhep.2008.06.003_bib68","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1086\/517339","article-title":"High rate of hepatitis C virus clearance in hemodialysis patients after interferon-\u03b1 therapy","volume":"176","author":"Izopet","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib69","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/ndt\/14.11.2704","article-title":"Efficacy and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C virus infection in haemodialysis patients","volume":"14","author":"Campistol","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib70","first-page":"285","article-title":"Effect of alpha 2b interferon treatment in haemodialysis patients with chronic hepatitis C","volume":"4","author":"Sporea","year":"2001","journal-title":"Rom J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.06.003_bib71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000045971","article-title":"Virological and histological responses to one-year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C","volume":"88","author":"Hanrotel","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.jhep.2008.06.003_bib72","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/ndt\/16.5.1017","article-title":"The tolerance and efficacy of interferon-alpha in hemodialysis patients with HCV infection: a multicentre, prospective study","volume":"16","author":"Degos","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib73","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000046646","article-title":"Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C","volume":"21","author":"Huraib","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jhep.2008.06.003_bib74","doi-asserted-by":"crossref","first-page":"c8","DOI":"10.1159\/000090505","article-title":"Efficacy of interferon-alpha in the treatment of chronic hepatitis C in dialysis patients: two therapeutic protocols compared","volume":"103","author":"Grgurevic","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jhep.2008.06.003_bib75","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/00365520600670034","article-title":"Liver steatosis in hepatitis C positive hemodialysis patients and factors affecting IFN-2a treatment","volume":"41","author":"Yildirim","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.06.003_bib76","first-page":"338","article-title":"Tolerance and efficacy of interferon-alpha in hemodialysis patients in Tripoli","volume":"17","author":"Buargub","year":"2006","journal-title":"Saudi J Kidney Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1478-3231.2005.01225.x","article-title":"Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis","volume":"26","author":"Rocha","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib78","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.transproceed.2005.02.054","article-title":"Treatment of hepatitis C with interferon in hemodialysis patients awaiting kidney transplant","volume":"37","author":"Rivera","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2008.06.003_bib79","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1572-0241.2003.07526.x","article-title":"Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety","volume":"98","author":"Russo","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.06.003_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2893.2008.00990.x","article-title":"Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials","volume":"15","author":"Fabrizi","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2008.06.003_bib81","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0272-6386(03)00417-7","article-title":"Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena ?","volume":"42","author":"Badalamenti","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib82","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000045125","article-title":"Interferon therapy for chronic hepatitis C in hemodialysis patients: increased serum levels of interferon","volume":"80","author":"Uchihara","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.jhep.2008.06.003_bib83","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1681\/ASN.V9122344","article-title":"Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications","volume":"9","author":"Rostaing","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2008.06.003_bib84","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.humpath.2003.08.012","article-title":"Reversibility of hepatitis C virus-related cirrhosis","volume":"35","author":"Pol","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhep.2008.06.003_bib85","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.510300319","article-title":"Consensus interferon study group. Racial differences in responses to therapy with interferon in chronic hepatitis C","volume":"30","author":"Reddy","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.06.003_bib86","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ndt\/16.1.193","article-title":"Safety of interferon and ribavirin therapy in hemodialysis patients with chronic hepatitis C: results of a pilot study","volume":"16","author":"Tan","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib87","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2893.2001.00300.x","article-title":"Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection- a pilot study","volume":"8","author":"Bruchfeld","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2008.06.003_bib88","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.transproceed.2004.07.025","article-title":"Alpha interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C","volume":"36","author":"Mousa","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2008.06.003_bib89","first-page":"370A","article-title":"Pegylated (40KD) interferon alfa-2a (Pegasys) is unaffected by renal impairment","volume":"32","author":"Martin","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.06.003_bib90","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2004.02014.x","article-title":"Pegylated interferon-alpha2a kinetics during experimental hemodialysis: impact of permeability and pore size of dialysers","volume":"20","author":"Barril","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2008.06.003_bib91","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/009127002401382713","article-title":"Single-dose pharmacokinetics and safety of pegylated interferon-\u03b12b in patients with chronic renal dysfunction","volume":"42","author":"Gupta","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jhep.2008.06.003_bib92","first-page":"326A","article-title":"Peginterferon alfa-2a (40KD) (Pegasys) can be administered safely in patients with end-stage renal disease","volume":"34","author":"Lamb","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.06.003_bib93","first-page":"794","article-title":"Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit","volume":"19","author":"Covic","year":"2006","journal-title":"J Nephrology"},{"key":"10.1016\/j.jhep.2008.06.003_bib94","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0041-1345(03)00446-9","article-title":"Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study","volume":"35","author":"Mukherjee","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2008.06.003_bib95","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2036.2004.01954.x","article-title":"Pegylated interferon alpha2b monotherapy for HD patients with chronic HCV","volume":"20","author":"Annichiarico","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2008.06.003_bib96","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/ndt\/gfh747","article-title":"Pegylated interferon for the treatment of hepatitis C virus in hemodialysis patients","volume":"20","author":"Teta","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib97","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ndt\/gfi231","article-title":"Randomized trial of pegylated interferon alpha-2b monotherapy in hemodialysis patients with chronic hepatitis C","volume":"21","author":"Russo","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib98","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.3748\/wjg.v12.i26.4191","article-title":"Pegylated interferon alpha2a treatment for chronic hepatitis C in patients on chronic hemodialysis","volume":"16","author":"Sporea","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.06.003_bib99","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.transproceed.2007.07.013","article-title":"Preliminary results of treatment with pegylated interferon alpha 2a for chronic hepatitis C virus in kidney transplant candidates on hemodialysis","volume":"39","author":"Casanovas-Taltavull","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2008.06.003_bib100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1440-1797.2006.00662.x","article-title":"Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection","volume":"12","author":"Chan","year":"2007","journal-title":"Nephrology"},{"key":"10.1016\/j.jhep.2008.06.003_bib101","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/gut.2007.133884","article-title":"Pegylated interferon alfa-2a versus standard interferon alfa-2a for treatment-na\u0131\u00a8ve dialysis patients with chronic hepatitis C: a randomized study","volume":"57","author":"Li","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.06.003_bib102","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3748\/wjg.14.255","article-title":"Efficacy and safety of pegylated-interferon \u03b1-2a in hemodialysis patients with chronic hepatitis C","volume":"14","author":"Ayaz","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.06.003_bib103","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2893.2005.00680.x","article-title":"Pegylated interferon and ribavirin treatment for hepatitis C in hemodialysed patients","volume":"13","author":"Bruchfeld","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2008.06.003_bib104","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jhep.2006.12.016","article-title":"The treatment of chronic hepatitis C with peginterferon alpha2a (40kDA) plus ribavirin in haemodialysed patients awaiting renal transplant","volume":"46","author":"Rendina","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.06.003_bib105","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ndt\/gfm724","article-title":"Pegylated interferon alfa-2a (40kD) and ribavirin in haemodialysis patients with chronic hepatitis C","volume":"23","author":"van Leusen","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib106","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/039139880803100404","article-title":"Treatment of dialysis patients with chronic hepatitis C using pegylated-interferon and low dose ribavirin","volume":"31","author":"Carriero","year":"2008","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jhep.2008.06.003_bib107","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","article-title":"Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients","volume":"59","author":"Rostaing","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2008.06.003_bib108","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0168-8278(03)00358-1","article-title":"Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha 2b and ribavirin","volume":"39","author":"Tang","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.06.003_bib109","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/01.TP.0000131151.07818.D7","article-title":"Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients","volume":"77","author":"Shu","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2008.06.003_bib110","first-page":"22","article-title":"Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation","volume":"12","author":"Schmitz","year":"2007","journal-title":"Ann Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib111","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1365-2036.2006.03151.x","article-title":"Meta-analysis: antiviral therapy of hepatitis C virus-related liver disease in renal transplant patients","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2008.06.003_bib112","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jcv.2003.10.001","article-title":"Amantadine therapy in renal transplant patients with hepatitis C virus infection","volume":"30","author":"Kamar","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhep.2008.06.003_bib113","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/01.TP.0000128911.87538.AA","article-title":"Histopathological efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C","volume":"78","author":"Fontaine","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2008.06.003_bib114","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0272-6386(03)00422-0","article-title":"Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology","volume":"42","author":"Kamar","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcv.2007.02.006","article-title":"Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone","volume":"39","author":"Calanca","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhep.2008.06.003_bib116","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1097\/01.ASN.0000079613.81511.3C","article-title":"Evidence that clearance of hepatitis C virus RNA after interferon therapy in dialysis patients is sustained after renal transplantation","volume":"14","author":"Kamar","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2008.06.003_bib117","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/039139880202501211","article-title":"Hepatitis C therapy with long term remission after renal transplantation","volume":"25","author":"Bunnapradist","year":"2002","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jhep.2008.06.003_bib118","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-6143.2003.00057.x","article-title":"Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV RNA clearance","volume":"3","author":"Cruzado","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib119","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0041-1345(00)00890-3","article-title":"Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients","volume":"32","author":"Gursoy","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2008.06.003_bib120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1440-1746.1998.tb00547.x","article-title":"Acute hepatitis C among renal failure patients on chronic haemodialysis","volume":"13","author":"Okuda","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2008.06.003_bib121","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5414\/CNP58143","article-title":"Natural history of acute HCV infection in hemodialysis patients","volume":"58","author":"Espinosa","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jhep.2008.06.003_bib122","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000045065","article-title":"Efficacy of interferon alpha in acute hepatitis C in patients on chronic hemodialysis","volume":"79","author":"Suleymanlar","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.jhep.2008.06.003_bib123","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2893.2001.00268.x","article-title":"Interferon therapy in hemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment","volume":"8","author":"Gursoy","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2008.06.003_bib124","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000079871","article-title":"Treatment of early diagnosed HCV infection in hemodialyzed patients with interferon-\u03b1","volume":"22","author":"Urbanek","year":"2004","journal-title":"Blood Purif"},{"key":"10.1016\/j.jhep.2008.06.003_bib125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.meg.0000252626.73172.f3","article-title":"Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance","volume":"19","author":"Rocha","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2008.06.003_bib126","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2458-7-50","article-title":"Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil","volume":"7","author":"Engel","year":"2007","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhep.2008.06.003_bib127","first-page":"293","article-title":"Treatment of acute hepatitis C virus infection with alpha interferon in patients on hemodialysis","volume":"16","author":"Al-Harbi","year":"2005","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib128","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/08860220701460160","article-title":"Acute hepatitis C in patients receiving hemodialysis","volume":"29","author":"Griveas","year":"2007","journal-title":"Ren Fail"},{"key":"10.1016\/j.jhep.2008.06.003_bib129","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archinte.167.12.1271","article-title":"Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease","volume":"167","author":"Tsui","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhep.2008.06.003_bib130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/MOT.0b013e3280105c5c","article-title":"Management of hepatitis B and C virus infection before and after renal transplantation","volume":"11","author":"Fabrizi","year":"2006","journal-title":"Curr Opinion Organ Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib131","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/ndt\/gfg209","article-title":"Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency","volume":"18","author":"Bruchfeld","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib132","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1046\/j.1523-1755.2003.00022.x","article-title":"Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy","volume":"63","author":"Rossi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib133","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1053\/ajkd.2001.29291","article-title":"Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis","volume":"38","author":"Garini","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib134","first-page":"51","article-title":"HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies","volume":"78","author":"Garini","year":"2007","journal-title":"Acta Biomed"},{"key":"10.1016\/j.jhep.2008.06.003_bib135","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritism Rheum"},{"key":"10.1016\/j.jhep.2008.06.003_bib136","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/039139880703000306","article-title":"Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials","volume":"30","author":"Fabrizi","year":"2007","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jhep.2008.06.003_bib137","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/ki.1994.471","article-title":"Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy","volume":"46","author":"Johnson","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2008.06.003_bib138","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.06.003_bib139","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2169\/internalmedicine.35.529","article-title":"Clinicopathological analysis and therapy in hepatitis C virus-associated nephropathy","volume":"35","author":"Komatsuda","year":"1996","journal-title":"Intern Med"},{"key":"10.1016\/j.jhep.2008.06.003_bib140","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S1590-8658(00)80335-7","article-title":"Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis","volume":"32","author":"Mazzaro","year":"2000","journal-title":"Digest Liver Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib141","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00005792-200209000-00005","article-title":"The clinical and morphologic spectrum of renal cryoglobulinemia","volume":"81","author":"Beddhu","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.jhep.2008.06.003_bib142","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2003.11.020","article-title":"Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinaemic membranoproliferative glomerulonephritis","volume":"43","author":"Alric","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2008.06.003_bib143","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2008.06.003_bib144","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel004","article-title":"Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in absence of steroids","volume":"45","author":"Quartuccio","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.jhep.2008.06.003_bib145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/rheumatology\/kel387","article-title":"Lack of efficacy of rituximab in a patient with essential mixed cryoglobulinemia","volume":"46","author":"Cohen","year":"2007","journal-title":"Rheumatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827808003802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827808003802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T22:26:30Z","timestamp":1709072790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827808003802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":145,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0168827808003802"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2008.06.003","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}